Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Total Non-Current Liabilities: 2020

Historic Total Non-Current Liabilities for Protagonist Therapeutics (PTGX) over the last 1 years, with Dec 2020 value amounting to $44.7 million.

  • Protagonist Therapeutics' Total Non-Current Liabilities fell 8.76% to $43.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $43.4 million, marking a year-over-year decrease of 8.76%. This contributed to the annual value of $44.7 million for FY2020, which is N/A change from last year.
  • According to the latest figures from FY2020, Protagonist Therapeutics' Total Non-Current Liabilities is $44.7 million.
  • Protagonist Therapeutics' 5-year Total Non-Current Liabilities high stood at $44.7 million for FY2020, and its period low was $44.7 million during FY2020.
  • Over the past 1 years, Protagonist Therapeutics' median Total Non-Current Liabilities value was $44.7 million (recorded in 2020), while the average stood at $44.7 million.